Wall Street brokerages expect WebMD Health Corp (NASDAQ:WBMD) to announce $177.76 million in sales for the current fiscal quarter, according to Zacks Investment Research. Five analysts have provided estimates for WebMD Health Corp’s earnings, with the highest sales estimate coming in at $181.80 million and the lowest estimate coming in at $175.40 million. WebMD Health Corp posted sales of $171.44 million in the same quarter last year, which suggests a positive year over year growth rate of 3.7%. The firm is expected to report its next quarterly earnings report on Tuesday, November 7th.

On average, analysts expect that WebMD Health Corp will report full year sales of $177.76 million for the current financial year, with estimates ranging from $715.00 million to $735.80 million. For the next financial year, analysts expect that the business will report sales of $740.33 million per share, with estimates ranging from $717.80 million to $774.90 million. Zacks’ sales averages are an average based on a survey of analysts that cover WebMD Health Corp.

WebMD Health Corp (NASDAQ:WBMD) last posted its earnings results on Tuesday, May 2nd. The health services provider reported $0.30 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.27 by $0.03. The company had revenue of $154.06 million for the quarter, compared to analyst estimates of $152.53 million. WebMD Health Corp had a return on equity of 26.73% and a net margin of 12.56%.

Several brokerages have recently weighed in on WBMD. Leerink Swann cut WebMD Health Corp from an “outperform” rating to a “market perform” rating and raised their price objective for the company from $60.00 to $66.50 in a report on Tuesday, July 25th. SunTrust Banks, Inc. cut WebMD Health Corp from a “buy” rating to a “hold” rating and raised their price objective for the company from $60.00 to $66.50 in a report on Tuesday, July 25th. Raymond James Financial, Inc. restated a “market perform” rating and issued a $66.50 price objective on shares of WebMD Health Corp in a report on Tuesday, July 25th. Citigroup Inc. cut WebMD Health Corp from a “buy” rating to a “neutral” rating and raised their price objective for the company from $62.00 to $66.50 in a report on Wednesday, July 26th. Finally, BidaskClub upgraded WebMD Health Corp from a “strong sell” rating to a “sell” rating in a report on Friday, June 23rd. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $64.40.

Shares of WebMD Health Corp (NASDAQ WBMD) opened at 66.31 on Friday. The firm has a 50-day moving average price of $59.21 and a 200 day moving average price of $54.48. The firm has a market cap of $2.41 billion, a price-to-earnings ratio of 34.59 and a beta of 0.77. WebMD Health Corp has a 12-month low of $48.10 and a 12-month high of $66.45.

A number of institutional investors have recently bought and sold shares of WBMD. Meadow Creek Investment Management LLC boosted its position in WebMD Health Corp by 10.0% in the first quarter. Meadow Creek Investment Management LLC now owns 1,936 shares of the health services provider’s stock worth $102,000 after buying an additional 176 shares during the last quarter. Envestnet Asset Management Inc. boosted its position in WebMD Health Corp by 4.0% in the fourth quarter. Envestnet Asset Management Inc. now owns 2,410 shares of the health services provider’s stock worth $119,000 after buying an additional 93 shares during the last quarter. Glen Harbor Capital Management LLC boosted its position in WebMD Health Corp by 10.0% in the first quarter. Glen Harbor Capital Management LLC now owns 2,464 shares of the health services provider’s stock worth $130,000 after buying an additional 224 shares during the last quarter. Asset Management One Co. Ltd. acquired a new position in WebMD Health Corp during the first quarter worth approximately $148,000. Finally, Elkfork Partners LLC boosted its position in WebMD Health Corp by 10.0% in the first quarter. Elkfork Partners LLC now owns 2,992 shares of the health services provider’s stock worth $158,000 after buying an additional 272 shares during the last quarter. Institutional investors and hedge funds own 92.08% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This news story was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.thecerbatgem.com/2017/08/15/177-76-million-in-sales-expected-for-webmd-health-corp-wbmd-this-quarter-updated.html.

WebMD Health Corp Company Profile

WebMD Health Corp. is a provider of health information services. The Company provides its services to consumers, physicians and other healthcare professionals through its Websites, mobile applications and health-focused publications. Advertisers and sponsors use The WebMD Health Network to reach and engage healthcare professionals and consumers who are interested in healthy living, wellness, diseases and conditions, and other health-related topics.

Get a free copy of the Zacks research report on WebMD Health Corp (WBMD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for WebMD Health Corp (NASDAQ:WBMD)

Receive News & Stock Ratings for WebMD Health Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WebMD Health Corp and related stocks with our FREE daily email newsletter.